Skip to main content

Table 2 Linear regression analysis of adiponectin, NT-proBNP and different clinical parameters

From: High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension

  Log Adiponectin Log NT-proBNP
  Non-adjusted Adjusted Non-adjusted Adjusted
mRAP 1.2 (− 0.4, 2.8) 0.133 0.1 (−1.5, 1.7) 0.903 2.2 (1.0, 3.3) < 0.001 1.7 (0.3, 3.0) 0.020
mPAP 7.7 (− 5.2, 20.6) 0.248 3.8 (− 10.5, 18.1) 0.601 15.8 (6.9, 24.7) < 0.001 24.7 (14.6, 34.8) < 0.001
MOS 3.5 (− 2.2, 9.2) 0.232 5.5 (− 0.9, 11.9) 0.096 −3.9 (−8.3, 0.6) 0.096 −5.3 (− 11.0, 0.5) 0.077
PVR 0.6 (− 2.7, 3.8) 0.731 − 1.1 (− 4.0, 1.8) 0.471 2.1 (− 0.3, 4.5) 0.092 2.7 (0.4, 4.9) 0.023
PI 2.2 (0.5, 4.0) 0.013 2.1 (0.2, 4.1) 0.036 1.0 (−0.3, 2.3) 0.150 0.7 (− 1.0, 2.4) 0.445
CI 0.1 (−0.5, 0.6) 0.862 0.2 (−0.4, 0.9) 0.477 − 0.6 (− 1.0, − 0.2) 0.005 −0.7 (− 1.3, − 0.2) 0.013
LA 4.3 (− 0.0, 8.6) 0.057 4.2 (− 0.6, 9.0) 0.089 3.5 (0.5, 6.5) 0.026 4.2 (0.2, 8.2) 0.048
LVEDD 2.4 (− 3.3, 8.2) 0.409 3.5 (− 3.2, 10.2) 0.311 1.2 (− 3.6, 6.0) 0.624 4.5 (− 2.0, 11.0) 0.181
LVESD 3.6 (− 1.1, 8.3) 0.139 3.8 (− 1.5, 9.0) 0.164 2.7 (− 1.1, 6.5) 0.176 4.7 (− 0.3, 9.7) 0.071
LVEF −8.5 (− 13.9, − 3.1) 0.003 − 8.3 (− 13.6, − 2.9) 0.004 −6.0 (− 10.4, − 1.6) 0.010 −5.8 (− 11.1, − 0.5) 0.038
RA 10.4 (1.6, 19.2) 0.023 7.5 (− 2.0, 16.9) 0.126 10.7 (6.0, 15.4) < 0.001 6.1 (0.4, 11.8) 0.043
RVEDD 9.5 (3.9, 15.0) 0.001 7.2 (1.2, 13.2) 0.022 10.2 (6.5, 14.0) < 0.001 10.4 (5.8, 14.9) < 0.001
TAPSE −4.7 (− 8.6, − 0.8) 0.022 − 4.9 (− 9.2, − 0.5) 0.036 −5.2 (− 7.8, − 2.5) < 0.001 −5.4 (− 9.4, − 1.5) 0.013
S‘ −3.0 (− 5.9, − 0.2) 0.042 −3.7 (− 6.7, − 0.7) 0.024 −2.2 (− 4.3, 0.0) 0.059 −2.0 (− 4.8, 0.9) 0.189
  1. Abbreviation: mRAP mean right atrial pressure, mPAP mean pulmonary arterial pressure, MOS mixed venous oxygen saturation, PVR pulmonary vascular resistance, PI pulmonary circulation index, CI cardiac index, LVEF left ventricular ejection fraction, LA left atrium, LVEDD left ventricular end diastolic dimension, LEVSD left ventricular end-systolic dimension, RA right atrium, RVEDD right ventricle end-diastolic dimension, TAPSE tricuspid annular plane systolic excursion, S′ systolic velocity of lateral tricuspid annulus displacement
  2. Adjusted, adjusted by age, gender, BMI, creatinine, TRIG/HDLC and glucose levels
  3. Depicted are beta-estimates with 95%-confidence intervals and p-value from linear regression analysis